Perceptive Advisors’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-186,662
| Closed | -$10.3M | – | 104 |
|
|
2024
Q4 | $10.3M | Sell |
186,662
-1,109,754
| -86% | -$61.4M | 0.28% | 58 |
|
|
2024
Q3 | $42.6M | Hold |
1,296,416
| – | – | 0.9% | 32 |
|
|
2024
Q2 | $35.2M | Hold |
1,296,416
| – | – | 0.85% | 34 |
|
|
2024
Q1 | $47.1M | Hold |
1,296,416
| – | – | 0.82% | 42 |
|
|
2023
Q4 | $26.3M | Hold |
1,296,416
| – | – | 0.59% | 46 |
|
|
2023
Q3 | $23M | Hold |
1,296,416
| – | – | 0.77% | 37 |
|
|
2023
Q2 | $23.4M | Hold |
1,296,416
| – | – | 0.68% | 44 |
|
|
2023
Q1 | $16.3M | Hold |
1,296,416
| – | – | 0.48% | 49 |
|
|
2022
Q4 | $19M | Hold |
1,296,416
| – | – | 0.53% | 44 |
|
|
2022
Q3 | $22.2M | Hold |
1,296,416
| – | – | 0.64% | 41 |
|
|
2022
Q2 | $18.9M | Hold |
1,296,416
| – | – | 0.59% | 42 |
|
|
2022
Q1 | $21.8M | Hold |
1,296,416
| – | – | 0.44% | 56 |
|
|
2021
Q4 | $29.2M | Hold |
1,296,416
| – | – | 0.45% | 53 |
|
|
2021
Q3 | $27.9M | Hold |
1,296,416
| – | – | 0.41% | 60 |
|
|
2021
Q2 | $37.6M | Hold |
1,296,416
| – | – | 0.49% | 51 |
|
|
2021
Q1 | $41.1M | Hold |
1,296,416
| – | – | 0.52% | 46 |
|
|
2020
Q4 | $53.6M | Buy |
+1,296,416
| New | +$53.6M | 0.58% | 43 |
|